IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories cash flow statement 1991–2026

IDEXX Laboratories's free cash flow over the last twelve months was 1.30B USD: operating cash flow of 1.42B USD less 114.99M USD of capital spending. That is 28.0% of its revenue and 16.34 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
1.18B1.06B887.87M845.04M679.09M744.84M582.13M427.79M377.05M263.27M222.05M
Depreciation and amortization
158.02M145.18M129.94M114.91M111.90M104.60M96.00M88.01M83.18M83.14M78.22M
Stock-based compensation
—0.0060.30M59.74M49.77M37.76M30.95M39.28M25.16M23.52M19.89M
Change in working capital
-52.12M-227.51M-133.24M-72.43M-273.53M-137.52M-31.76M-104.97M-91.64M8.38M3.00M
Change in receivables
-57.86M-68.72M-28.28M-53.87M-41.40M-33.14M-60.72M-22.47M-18.40M-24.92M-22.55M
Change in inventory
316.00K-789.00K-28.00M-28.65M-121.73M-52.92M-18.89M-37.31M-25.62M-19.06M7.65M
Change in payables
22.72M-8.57M8.09M-557.00K3.47M11.23M981.00K1.96M-166.00K1.39M2.12M
Change in other working capital
-17.29M-149.43M-85.04M10.65M-113.87M-62.70M46.87M-47.15M-47.45M50.97M15.79M
Other non-cash items
28.61M69.73M8.34M7.56M10.82M9.25M8.83M2.88M5.13M2.89M-9.48M
Operating cash flow
1.42B1.18B929.00M906.51M542.98M755.55M648.06M459.16M400.08M373.28M334.57M
Operating cash flow growth
+30.40%+26.81%+2.48%+66.95%-28.13%+16.59%+41.14%+14.77%+7.18%+11.57%+54.63%
Capital expenditure
-114.99M-124.68M-130.92M-133.63M-148.84M-119.55M-107.63M-155.22M-122.94M-76.70M-64.79M
Acquisitions
—0.00-77.70M0.00-46.51M-173.42M-1.75M-50.30M-22.50M-14.58M-1.96M
Purchases of investments
—-756.00K0.000.00-25.00M0.000.000.00-87.00K-334.16M-227.89M
Sales and maturities of investments
—0.001.56M0.0071.51M0.000.000.00284.13M286.76M203.86M
Other investing
—2.74M-10.00M8.38M-46.51M0.000.000.000.000.000.00
Investing cash flow
-335.27M-136.24M-207.06M-125.25M-195.35M-292.97M-109.38M-205.53M138.60M-138.69M-90.79M
Debt issued (repaid)
-131.00M-30.39M-75.00M-404.00M430.50M23.50M-94.65M-10.28M-256.04M44.00M38.00M
Shares issued
100.42M93.36M44.49M47.03M35.75M46.57M51.33M36.11M38.20M38.62M38.34M
Share buybacks
-1.05B-1.22B-837.03M-71.92M-819.71M-746.78M-182.82M-301.66M-369.32M-290.64M-304.09M
Dividends paid
—0.000.000.000.000.000.000.000.000.000.00
Other financing
-11.06M-7.24M-10.53M-13.11M-17.04M-20.70M-22.28M-10.43M-10.64M0.009.97M
Financing cash flow
-1.09B-1.16B-878.07M-442.00M-370.94M-697.41M-248.42M-286.41M-597.80M-208.02M-217.82M
Net change in cash
-10.63M-108.20M-165.67M341.39M-31.91M-239.47M293.60M-33.47M-63.88M32.77M25.91M
Free cash flow
1.30B1.05B798.08M772.88M394.15M636.00M540.44M303.93M277.15M296.57M269.78M
Free cash flow growth
+36.74%+31.99%+3.26%+96.09%-38.03%+17.68%+77.81%+9.66%-6.55%+9.93%+102.17%
Free cash flow margin
27.97%24.48%20.48%21.11%11.71%19.78%19.97%12.63%12.52%15.06%15.20%
Free cash flow per share
16.3413.069.599.204.667.356.233.473.133.312.97
Free cash flow per share growth
+39.71%+36.20%+4.17%+97.54%-36.58%+17.89%+79.50%+10.83%-5.39%+11.55%+108.32%
Interest paid
———————————
Income taxes paid
—0.000.000.000.000.000.000.000.000.000.00

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Figures underlined with dots are from the company's SEC filings, where our data provider's differ.

Common questions about IDEXX Laboratories's cash flow

Source: Financial Modeling Prep